BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 78.05
-2.50 (-3.10%)
At close: Oct 23, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €19.77 billion as of October 23, 2026. Its market cap has decreased by 10.12% in one year.
Market Cap
19.77B
Enterprise Value
6.35B
Revenue
2.65B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 19.77B, an increase of 626.54%. That is a compound annual growth rate of 32.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.77B | 1.38% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| Sartorius Aktiengesellschaft | 17.41B |
| Fresenius Medical Care AG | 10.72B |
| SCHOTT Pharma AG & Co. KGaA | 3.87B |
| Fielmann Group AG | 3.34B |